The latest developments in technological innovation, decentralised clinical trials, and patient experience, plus our groundbreaking mdtalk webinar series – delving into the most important issues in clinical research, with some of the industry’s most influential people.

FDA issues new draft guidance to improve diversity in clinical trial design
Posted | May 6, 2022The US Food and Drug Administration (FDA) is recommending sponsors include a plan to enrol more participants from underrepresented racial and ethnic populations into clinical trials. Under the new guidance,…